SPIRULINA KNOWLEDGE BASE

A 2016 conference abstract reports observations in 116 patients, without a comparison group. It cannot show Spirulina caused the reported changes.

A randomized 2019 study reported differences in selected blood and immune measures. It did not test fresh-frozen SPRU or cancer outcomes.

A review of phycocyanin studies covers experimental cancer models, not proven treatment in people. Its original conclusions do not apply automatically to SPRU.

A 2021 review discusses Spirulina research but cannot establish reduced cancer risk or prove the absence of adverse effects.

A 2022 review discusses Spirulina compounds and cancer models. The topic pages previously linked in this article are definitions, not primary studies.

A review discusses laboratory and animal studies of isolated C-phycocyanin. It says mechanisms remain unclear and does not establish clinical use.

A 2017 review covers phycocyanin research in laboratory and animal models. It does not establish phycocyanin as a cancer treatment for people.

A 2014 experimental study tested Spirulina and derived compounds in pancreatic-cancer models. It did not test treatment or prevention in people.